Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma (Q87505166)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 April 2014
edit
Language Label Description Also known as
English
Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma
scientific article published on 01 April 2014

    Statements

    Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit